The Migraine Drugs Market is experiencing robust growth as the acute treatment segment evolves beyond traditional triptans and nonsteroidal anti-inflammatory drugs to embrace novel, rapidly acting mechanisms that address the limitations of existing options. Many migraine patients experience inadequate response, recurrence, or contraindications to triptans, while others develop...